Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma
about
The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression.Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiological studiesThe expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphomaMultiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.Combination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma.Prognostic significance of peripheral monocytic myeloid-derived suppressor cells and monocytes in patients newly diagnosed with diffuse large b-cell lymphoma.Angiomirs expression profiling in diffuse large B-Cell lymphoma.Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.All That Wheezes Is Not Asthma: A Case of Diffuse Large B-Cell Lymphoma of the Larynx.Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis.
P2860
Q33616251-2CC4DCCA-D85C-454B-AACF-200FDCA11A78Q33718809-4BF51B9D-EF6B-4BC0-B202-CC837AD69862Q34543066-17CEF555-600F-4965-A25D-CF15D818602DQ35150618-A58EF248-6F6A-4126-B5B5-8CCBEABB2C6AQ35606714-B7CF83E6-9067-40FE-AC26-EDFC54E2CAE8Q35755485-55FC0E66-2819-4590-969D-1DF666FBC500Q36093288-18BB97C3-C2E3-49E8-8FA0-FB10325FE417Q36317453-F77ACE59-C9B9-40BE-9B45-7B7AE67840C5Q36782590-0D421A23-6F55-46F8-8635-19F47948DD07Q37109671-17B0B334-40DD-4B5B-92F8-03CEB1B9E735Q37706368-927F251E-B7A2-4A37-A313-5918F21C16E9Q37726952-2C97761C-2942-412B-B15F-0B02FA2394DAQ38985973-B960677D-2F8A-479F-A737-4B3CBFAEFDDAQ43114005-EED04316-5CBF-4DAB-9445-F643BB8A283E
P2860
Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@ast
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@en
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@nl
type
label
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@ast
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@en
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@nl
prefLabel
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@ast
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@en
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@nl
P1476
Paramount prognostic factors t ...... diffuse large B-cell lymphoma
@en
P2093
Laurie H Sehn
P356
10.1182/ASHEDUCATION-2012.1.402
P407
P577
2012-01-01T00:00:00Z